BTOG
@btog.bsky.social
180 followers 58 following 180 posts
British Thoracic Oncology Group (BTOG) - multi-disciplinary group for professionals involved with thoracic malignancies.
Posts Media Videos Starter Packs
btog.bsky.social
Screening Event
🎉 Today’s the day!
The #BTOGScreeningEvent kicks off in London with vital updates on #LungCancer screening across the UK.
We’ll be talking strategy, challenges, and the future of screening.
Follow along and join the conversation ⬇️ #BTOGScreeningEvent
#LCSM
Reposted by BTOG
nlca-natcan.bsky.social
The NLCA October quarterly data dashboard is now live! This includes the latest English data up to 31 Dec 2024:
rcs-ceu.shinyapps.io/NLCA/

@hqip.bsky.social @btog.bsky.social #LungCancer
rcs-ceu.shinyapps.io
btog.bsky.social
We’re ready. Are you?
👥 Meet national experts
🧠 Debate real-world screening issues
🗣️ Submit your questions live
📍London | ⏰ Doors open 08:30
See you tomorrow at the #BTOGScreeningEvent
#LungCancer #LCSM
btog.bsky.social
💡 Discover the latest in mutation-driven lung cancer research.
Session 4 with @ruthstraussfdn.bsky.social rings science, debate, and progress together.
📅 13 Nov | 📍 The View, London
🔗 www.btog.org/non-smo...
#LungCancer #LCSM #NonSmokingLungCancer
btog.bsky.social
1 week to go!
⏳ The #BTOGScreeningEvent is almost here. Join the lung cancer screening community in London for vital updates, peer discussions, and practical challenges.
Don’t miss it — register today: www.btog.org/btog-sc...
#LungCancer #LCSM
btog.bsky.social
"🧩 Local Consolidative Therapy – survival benefits or overtreatment?
Hear from experts tackling difficult questions in non-smoking lung cancer.
🎫 Register today
🔗 www.btog.org/non-smo...
#LungCancer #LCSM #NonSmokingLungCancer
With @RuthStraussFdn"
btog.bsky.social
Registration and abstract submissions are now open for #BTOG26 our 24th Annual Conference, which will be held at the EICC in Edinburgh.

Full details are on the website www.btog.org/24th-btog-an...

#LCSM #lungcancer
Reposted by BTOG
allyouneedislungs.bsky.social
Ruth Strauss Foundation have grants up to £50,000 available for research into Non-Smoking #LungCancer; to improve understanding, diagnosis & quality of life 🫁

🗓️ Apply by 10 Jan 2026 #LCSM

ruthstraussfoundation.com/grants-progr...
btog.bsky.social
"Psychological distress in screening is real.
How can we recognise & manage it effectively?
Join the discussion at #BTOGScreeningEvent
✅ Full programme: www.btog.org/btog-sc...
#LungCancer #LCSM
"
btog.bsky.social
"🔍 Brain metastases + the DVLA – treatment implications for your practice.
Don’t miss this timely session in our Advanced Disease module.
📍 London | 📅 13 Nov
#LungCancer #LCSM #NonSmokingLungCancer
🔗 www.btog.org/non-smo...
with @RuthStraussFdn"
btog.bsky.social
"Peer support is vital in lung cancer screening delivery.
Our fireside chat will feature first-hand insights from teams on the ground — with real-world Q&A from attendees.
🗓️ 14 Oct 2025 | 💬 Bring your questions!
#LungCancer #LCSM #BTOGScreeningEvent
"
btog.bsky.social
"🧠 MRD: Molecular Residual Disease – is it ready for clinical use in early NSCLC?
Get the latest on 13 Nov with @RuthStraussFdn.
🔗 www.btog.org/non-smo...
#LungCancer #LCSM #NonSmokingLungCancer"
btog.bsky.social
New Podcast Alert!

BTOG does … Neo-adjuvant / peri-operative chemoimmunotherapy

@tnewsomdavis.bsky.social & Emma O'Dowd talk to Jason Adhikaree.

Subscribe via Apple App Store, Spotify or Amazon Music – just search BTOG or listen via the BTOG website.
www.btog.org/btog-podcasts/
#LCSM #lungcancer
btog.bsky.social
"Just 4 weeks to go!
Ready to debate hot topics in #LungCancer screening?
Our quick-fire debate session features rapid PRO/CON talks on controversial issues — don’t miss it.
Register now 👉 www.btog.org/btog-sc...
#LCSM #BTOGScreeningEvent
"
btog.bsky.social
Durvalumab can only be used if the company provides it according to the commercial arrangement.

For full details and the documents, please see the NICE website www.nice.org.uk/guidance/gid...
Final draft guidance | Project documents | Durvalumab for treating limited-stage small-cell lung cancer after platinum-based chemoradiotherapy [ID5073] | Guidance | NICE
www.nice.org.uk
btog.bsky.social
BTOG wishes to inform members of a new NICE release that has been published today.

NICE has recommended Durvalumab, within its marketing authorisation, as an option to treat limited-stage small-cell lung cancer that has not progressed after platinum-based chemoradiotherapy in adults.
#LCSM
Reposted by BTOG
btog.bsky.social
"🎯 Targeted therapies in chemoradiotherapy paradigms – how far have we come in managing non-resectable disease?
📅 BTOG Non-Smoking LC Update with @RuthStraussFdn
🗓️ 13 Nov | 📍 London
🔗 www.btog.org/non-smo...
#LungCancer #LCSM #NonSmokingLungCancer"
btog.bsky.social
"🔍 Tobacco dependency support in screening: What does optimal delivery look like?
Join us at #BTOGScreeningEvent to hear expert views & engage in live panel Q&A.
Details & booking 👉 www.btog.org/btog-sc...
#LungCancer #LCSM
"
btog.bsky.social
The global thoracic oncology community is at #WCLC25 and BTOG is no exception! #LCSM
btog.bsky.social
"🔬 Session 3: Focus on early and locally advanced disease.
We cover everything from peri-operative strategies to MRD readiness. With @RuthStraussFdn
📆 Register now: 13 Nov
🔗 www.btog.org/non-smo...
#LungCancer #LCSM #NonSmokingLungCancer"
btog.bsky.social
Remember that BTOG members now receive 30% off IASLC membership as part of our new partnership with IASLC. You also receive a number of other benefits, including discounted admission to WCLC.
btog.bsky.social
For the first time BTOG executives, Dawn and Gina, are thrilled to be attending #WCLC25. If you are attending, please visit them at Table Top 6.